Obtaining antibody genes is a prerequisite for antibody engineering and antibody humanization and is also a key step in patent applications for important monoclonal antibody gene sequences. Gxene Biotech has established a comprehensive antibody sequencing platform and applies mature sequencing technologies to provide customers with one-stop services from antigen to antibody gene sequence acquisition.
In addition, Gxene Biotech has deep knowledge reserves in antibody research and a skilled R&D team. After years of development, it has established a complete set of upstream and downstream antibody-related services. We can perform recombinant antibody preparation, antibody purification, and other services according to customer needs. We also leverage our technical advantages to provide customers with services including antibody modification, antibody pairing, custom ELISA development, and antibody-antigen binding kinetics research.
Our Advantages
—Experienced technical support and antibody service team, high-standard quality requirements
—Provide antibody sequencing for common species and different subtypes, with full-length sequencing available
—Mature and rapid experimental, analytical, and delivery speed
—Comprehensive service content: provide one-stop technical services from antibody preparation, antibody sequencing, antibody pairing, and antibody modification to ELISA kit development
Antibody Sequencing Service
Gxene Biotech uses the high-quality Orbitrap Fusion Lumos mass spectrometer and fully functional antibody sequencing data processing software, combined with gene sequencing and bioinformatics databases, to establish a new-generation antibody sequencing platform, achieving rapid and accurate analysis of antibody primary structure, thereby ensuring the accuracy of every antibody sequencing project. We can tailor complete primer design and sequencing schemes while optimizing economic and time costs. We can not only provide Antibody Sequencing Service for all species, but also provide hybridoma sequencing services for customers.
Obtaining the gene sequence of the variable region of a monoclonal antibody from hybridoma cells is a prerequisite for obtaining recombinant antibodies on a large scale. Gxene Biotech's hybridoma sequencing service provides key support for antibody cell engineering. Through RACE technology, variable region gene information is rapidly obtained, ensuring the authenticity of the obtained antibody variable region sequence. Throughout the entire process, we retain the original experimental data and sequencing results to coordinate with your later project applications and intellectual property applications.
Antibody Modification
Immunological detection usually involves antibody modification. Gxene Biotech can provide Antibody Enzyme Labeling and Crosslinking Service. Our scientists can provide you with high-quality antibody labeling services, including fluorescent molecule labeling (FITC, FAM, etc.), carrier conjugation (agarose beads, magnetic bead conjugation, etc.), enzyme labeling (HRP, AP, etc.), and biotin labeling, etc. The antibody modification services provided by Gxene Biotech can bring convenience to customers' research and other downstream applications. We can also provide customers with personalized solutions, selecting suitable labels or labeling methods, optimizing labeling methods, and meeting your specific needs.


Figure 1 Types of Antibody Labeling
Antibody Pairing (Custom ELISA Development)
Gxene Biotech has persistently provided high-quality antibody pairing–custom ELISA development services for many years.
Antibody pairing is crucial to ELISA kit development. Protein quantification and other immunological detection techniques all rely on high-quality matched antibody pairs. We have a mature monoclonal antibody technology platform, ensuring immunization quantity and a high antibody pairing success rate.
Our antibody team members have rich experience in clinical detection method development and can provide you with high-quality enzyme-linked immunosorbent assay kit development services, including sensitivity validation, linear range validation, reproducibility validation, specificity validation, and thermal stability (37 °C or 25 °C thermal stability) validation. We have successfully developed small-molecule detection kits with a detection sensitivity of 0.1 ppb for customers.

Figure 2 Principle of ELISA Measurement
Antibody-Antigen Binding Kinetics Research
We can provide customers with antibody affinity detection services based on BIAcore technology. This technology is suitable for vaccine detection method development and can evaluate the immunogenicity of antigens in animals in vitro. It can also solve the difficulty of selecting different antibodies against the same antigen during vaccine development and the problem of antibody affinity determination in rapid detection methods.
Scan with WeChat to follow us.






